ProCE Banner Activity

Translating the Latest Advances Into Precision Care for Advanced ALK-Positive NSCLC

Slideset

Download this slideset featuring expert perspectives on the use of targeted therapy for advanced ALK-positive NSCLC, with a focus on recent practice-changing studies.

Released: May 02, 2025

Expiration: May 01, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.